These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 21450629)

  • 21. Does the constellation of risk factors with and without abdominal adiposity associate with different cardiovascular mortality risk?
    Gao W;
    Int J Obes (Lond); 2008 May; 32(5):757-62. PubMed ID: 18209738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The US National Cholesterol Education Programme Adult Treatment Panel III (NCEP ATP III): prevalence of the metabolic syndrome in postmenopausal Latin American women.
    Royer M; Castelo-Branco C; Blümel JE; Chedraui PA; Danckers L; Bencosme A; Navarro D; Vallejo S; Espinoza MT; Gómez G; Izaguirre H; Ayala F; Martino M; Ojeda E; Onatra W; Saavedra J; Tserotas K; Pozzo E; Manriquez V; Prada M; Grandia E; Zuniga C; Lange D; Sayegh F;
    Climacteric; 2007 Apr; 10(2):164-70. PubMed ID: 17453865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The metabolic syndrome: similar deleterious impact on all-cause mortality in hypertensive and normotensive subjects.
    Pannier B; Thomas F; Bean K; Jégo B; Benetos A; Guize L
    J Hypertens; 2008 Jun; 26(6):1223-8. PubMed ID: 18475161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiorespiratory fitness attenuates the effects of the metabolic syndrome on all-cause and cardiovascular disease mortality in men.
    Katzmarzyk PT; Church TS; Blair SN
    Arch Intern Med; 2004 May; 164(10):1092-7. PubMed ID: 15159266
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a Chinese cohort study.
    Chen JH; Chuang SY; Chen HJ; Yeh WT; Pan WH
    Arthritis Rheum; 2009 Feb; 61(2):225-32. PubMed ID: 19177541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Very low-grade albuminuria reflects susceptibility to chronic kidney disease in combination with cardiovascular risk factors.
    Heo NJ; Ahn JM; Lee TW; Chin HJ; Na KY; Chae DW; Kim S
    Hypertens Res; 2010 Jun; 33(6):573-8. PubMed ID: 20379188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic syndrome is associated with better nutritional status, but not with cardiovascular disease or all-cause mortality in patients on haemodialysis.
    Xie Q; Zhang AH; Chen SY; Lai X; Zhang F; He L; Zhuang Z; Zhu N; Fan MH; Wang T
    Arch Cardiovasc Dis; 2012 Apr; 105(4):211-7. PubMed ID: 22633295
    [TBL] [Abstract][Full Text] [Related]  

  • 28. All-cause mortality associated with specific combinations of the metabolic syndrome according to recent definitions.
    Guize L; Thomas F; Pannier B; Bean K; Jego B; Benetos A
    Diabetes Care; 2007 Sep; 30(9):2381-7. PubMed ID: 17563336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic syndrome and 10-year cardiovascular disease risk in the Hoorn Study.
    Dekker JM; Girman C; Rhodes T; Nijpels G; Stehouwer CD; Bouter LM; Heine RJ
    Circulation; 2005 Aug; 112(5):666-73. PubMed ID: 16061755
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The metabolic syndrome defined by modified International Diabetes Federation criteria and mortality: a 9-year follow-up of the aged in Finland.
    Salminen M; Kuoppamäki M; Vahlberg T; Räihä I; Irjala K; Kivelä SL
    Diabetes Metab; 2010 Dec; 36(6 Pt 1):437-42. PubMed ID: 20708423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The separate and combined effects of adiposity and cardiometabolic dysfunction on the risk of recurrent cardiovascular events and mortality in patients with manifest vascular disease.
    van der Leeuw J; van der Graaf Y; Nathoe HM; de Borst GJ; Kappelle LJ; Visseren FL;
    Heart; 2014 Sep; 100(18):1421-9. PubMed ID: 24817441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome.
    Meigs JB; Rutter MK; Sullivan LM; Fox CS; D'Agostino RB; Wilson PW
    Diabetes Care; 2007 May; 30(5):1219-25. PubMed ID: 17259468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypertension, concurrent cardiovascular risk factors and mortality: the Singapore Cardiovascular Cohort Study.
    Lee J; Ma S; Heng D; Chew S; Hughes K; Tai E
    J Hum Hypertens; 2008 Jul; 22(7):468-74. PubMed ID: 18337755
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sodium and potassium intake and mortality among US adults: prospective data from the Third National Health and Nutrition Examination Survey.
    Yang Q; Liu T; Kuklina EV; Flanders WD; Hong Y; Gillespie C; Chang MH; Gwinn M; Dowling N; Khoury MJ; Hu FB
    Arch Intern Med; 2011 Jul; 171(13):1183-91. PubMed ID: 21747015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolic syndrome, cardiovascular disease, and risk for chronic kidney disease in an Italian cohort: analysis of the INCIPE study.
    Ferraro PM; Lupo A; Yabarek T; Graziani MS; Bonfante L; Abaterusso C; Gambaro G;
    Metab Syndr Relat Disord; 2011 Oct; 9(5):381-8. PubMed ID: 21711121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. All-cause and cardiovascular mortality using the different definitions of metabolic syndrome.
    Benetos A; Thomas F; Pannier B; Bean K; Jégo B; Guize L
    Am J Cardiol; 2008 Jul; 102(2):188-91. PubMed ID: 18602519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and clinical characteristics of metabolic syndrome for at-risk people in a rural community.
    Oh EG; Bang SY; Hyun SS
    Metab Syndr Relat Disord; 2009 Feb; 7(1):11-5. PubMed ID: 18759659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of metabolic syndrome in Saudi adult soldiers.
    Al-Qahtani DA; Imtiaz ML
    Saudi Med J; 2005 Sep; 26(9):1360-6. PubMed ID: 16155648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association between metabolic syndrome, microalbuminuria and impaired renal function in the general population: impact on cardiovascular disease and mortality.
    Klausen KP; Parving HH; Scharling H; Jensen JS
    J Intern Med; 2007 Oct; 262(4):470-8. PubMed ID: 17875184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events.
    Laish I; Braun M; Mor E; Sulkes J; Harif Y; Ben Ari Z
    Liver Transpl; 2011 Jan; 17(1):15-22. PubMed ID: 21254340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.